LIQUIDMATE
"LIQUIDMATE" is a word mark owned by Auson Pharmaceuticals Inc., filed at the USPTO on October 23, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since October 23, 2026
- Filed
- October 23, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50178549
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns LIQUIDMATE
The owner and representative on file with the office.
Owner
Auson Pharmaceuticals Inc.
Bridgewater, United States
Representative
Christopher D. Olszyk, Jr.
Fox Rothschild LLP
What the mark covers
The products and services LIQUIDMATE is filed for, grouped by Nice class.
drug and food delivery agents in the form of tablets, capsules or powder for suspending drugs or food and facilitating delivery for use in a wide variety of pharmaceutical or food products; pharmaceutical preparations, namely, a drug delivery system consisting of compounds in a unitary solid dosage form for the dispersion of a wide variety of therapeutic agents; pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About LIQUIDMATE
Who owns the trademark "LIQUIDMATE"?
The USPTO trademark "LIQUIDMATE" (application 50178549) is owned by Auson Pharmaceuticals Inc.
What is the status of "LIQUIDMATE"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull LIQUIDMATE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a16e04-0547-77fc-b5a8-cba4a73960c6
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a16e04-0547-77fc-b5a8-cba4a73960c6",
"object": "trademark",
"mark_text": "LIQUIDMATE",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50178549",
"filing_date": "2026-10-23",
"nice_classes": [
5
],
"owners": [
{
"name": "Auson Pharmaceuticals Inc.",
"entity_id": null
}
]
}